
    
      A European, prospective, multi-center Post-Market Clinical Follow-up (PMCF) trial providing
      additional data including health economics data to support the use of the ELUVIA stent in the
      treatment of lesions located in the femoropopliteal arteries.

      The objective of the study is to collect additional data including health economics data to
      support the use of the ELUVIA Drug-Eluting Vascular Stent System (ELUVIA Stent) for treating
      Superficial Femoral Artery (SFA) and/or Proximal Popliteal Artery (PPA) lesions.
    
  